Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James T Kenney

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
The Tiered Pharmacy Benefit: Challenges in Today's Health Care MarketJames T Kenney
The American Journal of Managed Care|January 19, 2013
Managing the evolving complexity of pharmacologic treatment: comparative effectiveness research, pharmacoeconomic data analyses, and other decision support toolsJames T Kenney
American Health & Drug Benefits|February 8, 2020
Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm AdoptionCori Gray, James T Kenney
Journal of Managed Care & Specialty Pharmacy|April 23, 2024
A primer on brand-name prescription drug contractingJames T Kenney, Shellie Keast
Journal of Managed Care & Specialty Pharmacy|May 31, 2021
An analysis of member retention patterns for adult rare disease cohorts to support evaluating multiyear payment arrangements for novel therapiesE Anne Jackson, Brenda Runyan, Luke Metz, et al.
Journal of Managed Care & Specialty Pharmacy|October 5, 2016
Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management UpdateChristopher L Bowlus, James T Kenney, Gary Rice, et al.
Journal of Managed Care & Specialty Pharmacy|May 4, 2026
Principles and practices for successful gene therapy innovative contracting: insights from a multistakeholder conveningTyler D Wagner, Jacqlyn W Riposo, Kendra M Gould, et al.
Journal of Managed Care & Specialty Pharmacy|October 20, 2021
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utilityChristopher Arnell, Martin Bergman, Dhiman Basu, et al.
Pharmacoeconomics|November 27, 2025
Innovative Contracting for Gene Therapies: Current Landscape and Perspectives on the Future of Gene Therapy Financing in the USATyler D Wagner, Jacqlyn W Riposo, Kendra M Gould, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report, Burt Zweigenhaft, Linda Bosserman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
The Tiered Pharmacy Benefit: Challenges in Today's Health Care MarketJames T Kenney
The American Journal of Managed Care|January 19, 2013
Managing the evolving complexity of pharmacologic treatment: comparative effectiveness research, pharmacoeconomic data analyses, and other decision support toolsJames T Kenney
American Health & Drug Benefits|February 8, 2020
Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm AdoptionCori Gray, James T Kenney
Journal of Managed Care & Specialty Pharmacy|April 23, 2024
A primer on brand-name prescription drug contractingJames T Kenney, Shellie Keast
Journal of Managed Care & Specialty Pharmacy|May 31, 2021
An analysis of member retention patterns for adult rare disease cohorts to support evaluating multiyear payment arrangements for novel therapiesE Anne Jackson, Brenda Runyan, Luke Metz, et al.
Journal of Managed Care & Specialty Pharmacy|October 5, 2016
Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management UpdateChristopher L Bowlus, James T Kenney, Gary Rice, et al.
Journal of Managed Care & Specialty Pharmacy|May 4, 2026
Principles and practices for successful gene therapy innovative contracting: insights from a multistakeholder conveningTyler D Wagner, Jacqlyn W Riposo, Kendra M Gould, et al.
Journal of Managed Care & Specialty Pharmacy|October 20, 2021
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utilityChristopher Arnell, Martin Bergman, Dhiman Basu, et al.
Pharmacoeconomics|November 27, 2025
Innovative Contracting for Gene Therapies: Current Landscape and Perspectives on the Future of Gene Therapy Financing in the USATyler D Wagner, Jacqlyn W Riposo, Kendra M Gould, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report, Burt Zweigenhaft, Linda Bosserman, et al.
Pageof 1